EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing a decade of leukaemia-related premature mortality costs: impact on productivity loss in Spain

Josep Darbà, Meritxell Ascanio, Ainoa Agüera

The European Journal of Health Economics · 2025

DOI: 10.1007/s10198-024-01727-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The European Journal of Health Economics, 2025. Verfasst von Josep Darbà und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Economics, Universitat de Barcelona, Diagonal 696, Barcelona, 08034, Spain. darba@ub.edu. Hauptthemen laut MEDLINE: Mortality, Premature, Leukemia, Efficiency, Cost of Illness. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitat de Barcelona.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cancer mortality is one of the dominant causes of productivity loss; and within all cancer sites, blood cancer is the fourth most common cause of death in Spain. Thus, its impacts in work productivity are a major concern and represent a high social impact. The aim of this study was to evaluate the productivity losses resulting from of premature deaths due to leukaemia in Spain.

Methods

The productivity costs stemming from premature mortality due to leukaemia were estimated using the human capital method. Information pertaining to mortality rates, typical incomes, and joblessness figures was gathered throughout a decade-long period spanning from 2012 to 2021.

Results

Leukaemia caused 40% of haematological malignancies losses. It represented a 3.39% of all cancer-related deaths. In addition, it was responsible for 7,851 years of potential productive life lost (YPLPLL) in 2021, and productivity losses of €4,206.52 million over the 10-year period. All these numbers are relevant for Spain as will help on a more efficient distribution of resource.

Conclusions

These productivity losses obtained, highlight the burden of leukaemia on the Spanish population, providing novel data on the number of deaths, trends and productivity losses for this type of cancer. This evaluation offers fresh insights that can aid policymakers in efficiently distributing resources, thereby lessening the economic burden it imposes on individuals of working age.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mortality, PrematureLeukemiaEfficiencyCost of IllnessHumansSpainMaleFemaleMiddle AgedAdultAgedYoung AdultAdolescent

Stichwörter der Autor:innen

Human capital approach.LeukaemiaProductivity costsYears of potential productive life lost

Autor:innen und Institutionen

  • Department of Economics, Universitat de Barcelona, Diagonal 696, Barcelona, 08034, Spain. darba@ub.edu.
  • BCN Health Economics & Outcomes Research S.L. Travessera de Gràcia, 62, Barcelona, 08006, Spain.

Förderung

  • Universitat de Barcelona

Zitieren

APA

Darbà, J., Ascanio, M., & Agüera, A. (2025). Assessing a decade of leukaemia-related premature mortality costs: impact on productivity loss in Spain. The European Journal of Health Economics. https://doi.org/10.1007/s10198-024-01727-6

Vancouver

Darbà J, Ascanio M, Agüera A. Assessing a decade of leukaemia-related premature mortality costs: impact on productivity loss in Spain. The European Journal of Health Economics. 2025. doi:10.1007/s10198-024-01727-6

BibTeX
@article{Darb2025,
  author = {Darbà, Josep and Ascanio, Meritxell and Agüera, Ainoa},
  title = {Assessing a decade of leukaemia-related premature mortality costs: impact on productivity loss in Spain},
  journal = {The European Journal of Health Economics},
  year = {2025},
  doi = {10.1007/s10198-024-01727-6}
}
Kostenlos starten →